Report overview
Progesterone is a steroid hormone involved in the female menstrual cycle, pregnancy, and the embryonic development of humans and other species. Progesterone belongs to a class of hormones called progestogens. This steroid hormone is produced in the ovaries, the adrenal glands, and in the placenta during pregnancy.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cells. This report contains market size and forecasts of Allogeneic Stem Cells in global, including the following market information:
Global Allogeneic Stem Cells Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Allogeneic Stem Cells market was valued at US$ 779.2 million in 2022 and is projected to reach US$ 1513.9 million by 2029, at a CAGR of 10.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the past, in the field of upstream production of steroid drugs, due to the late start of domestic biotechnology research, it was relatively backward compared to foreign manufacturers. However, after decades of development, China's production technology has been continuously improved, and its cost advantage is more obvious. Now, domestic steroid raw material manufacturers have gradually become the mainstream suppliers of steroid drug products, and foreign steroid drug giants have used steroid drugs upstream. Procurement of product starting materials and intermediates shifted to Asia-Pacific region, mainly China, and global steroid drug production center gradually moved to Asia-Pacific region.
The Progesterone is a high concentration industry. The annual production is about few hundred Tonnes. Currently, the global top three manufacturers are: Merck, Teva Generics, Zhejiang Xianju Pharmaceutical. Their revenue market share is about 52%. In short future, the competition pattern will not change.
We surveyed the Allogeneic Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allogeneic Stem Cells Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Allogeneic Stem Cells Market Segment Percentages, by Type, 2022 (%)
Progesterone Oral
Progesterone Injection
Progesterone Suspended/Gel
Global Allogeneic Stem Cells Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Allogeneic Stem Cells Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacies & Drug Stores
Global Allogeneic Stem Cells Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Allogeneic Stem Cells Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Allogeneic Stem Cells revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Allogeneic Stem Cells revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva Generics
Zhejiang Medicine
Zhejiang Aisheng Pharmaceutical
Besins Healthcare
Virtus Pharmaceuticals
BionPharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Allogeneic Stem Cells, market overview.
Chapter 2: Global Allogeneic Stem Cells market size in revenue.
Chapter 3: Detailed analysis of Allogeneic Stem Cells company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Allogeneic Stem Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
